Asset Details
Do you wish to reserve the book?
The “Asian Paradox” in multiple primary lung cancer: a geographic monopole driven by phenotypic divergence
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The “Asian Paradox” in multiple primary lung cancer: a geographic monopole driven by phenotypic divergence
Do you wish to request the book?
The “Asian Paradox” in multiple primary lung cancer: a geographic monopole driven by phenotypic divergence
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The “Asian Paradox” in multiple primary lung cancer: a geographic monopole driven by phenotypic divergence
2026
Overview
The global clinical trial landscape for multiple primary lung cancer (MPLC) exhibits a striking geographic anomaly. Through a systematic analysis of 8212 lung cancer registrations (2015–2024), we identified a cohort of 17 trials explicitly targeting MPLC. Analysis revealed an absolute geographic monopole: 100% of these trials were investigator-initiated in China, with a complete absence of active protocols in Western registries. We argue that this segregation is not accidental but driven by the “Asian phenotype”,which is characterized by indolent, multifocal ground-glass nodules (GGNs), demands lung-sparing local strategies distinct from the systemic paradigms favored in the West. We urge the international community to transition from universal guidelines to phenotype-stratified management frameworks.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
